Cargando…
Immunogenic cell stress and injury versus immunogenic cell death: implications for improving cancer treatment with immune checkpoint blockade
Inducing immunogenic tumor cell death to stimulate the response to immune checkpoint blockade has not yet been effectively translated into clinical practice. We recently discovered that stressed/injured but still viable tumor cells are critical for T-cell priming and substantially improve responses...
Autores principales: | Sriram, Ganapathy, Emmons, Tiffany R., Milling, Lauren E., Irvine, Darrell J., Yaffe, Michael B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986242/ https://www.ncbi.nlm.nih.gov/pubmed/35402699 http://dx.doi.org/10.1080/23723556.2022.2039038 |
Ejemplares similares
-
Immunogenicity of cell death driven by immune effectors
por: Galluzzi, Lorenzo, et al.
Publicado: (2020) -
Lysosomal lipid peroxidation mediates immunogenic cell death
por: Phadatare, Pravin, et al.
Publicado: (2023) -
Combining immune checkpoint blockade with ATP-based immunogenic cell death amplifier for cancer chemo-immunotherapy
por: Zhang, Jiulong, et al.
Publicado: (2022) -
Hypothesis on the possible relevance of the immunogenic cell death in the treatment of gestational trophoblastic neoplasms
por: Frega, G., et al.
Publicado: (2021) -
TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
por: Reilley, Matthew J., et al.
Publicado: (2019)